Sidekick: digital therapeutics partnership with Pfizer
Digital therapeutics company Sidekick Health has announced a partnership with Pfizer to launch an an integrated digital therapeutics (DTx) solution for improving the outcomes of patients with atopic dermatitis. The companies will be rolling out the DTx offering first in the UK, then followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022.
Tryggvi Thorgeirsson, CEO and co-founder of Sidekick, said, “At Sidekick, it’s always been our ambition to help as many people as possible to make long-lasting improvements to their disease management, with the aim of improving people’s health outcomes and quality of life. Our work with Pfizer escalates our mission to bring digital therapeutics into the homes of people around the world.”
